CLAIMS made by former Olympic swimmer, Lisa Curry, that hormone replacement therapy (HRT) is "proven to increase women's risk of breast cancer", are being dismissed as "a load of codswallop" by experts.
Curry's controversial views were released in a statement to promote her upcoming appearance on The All New Monty: Ladies Night, raised the ire of International Menopause Society President and Monash University Professor of Women's Health, Susan Davis.
The Sydney Morning Herald reported that Curry had promoted "natural" treatments including her own Happy Hormones brand.
Davis told the paper that suggesting alternative products as a primary treatment option for treating menopausal symptoms could "unwittingly devastate the lives of women".
"The data is old, it is not relevant to the hormone therapy regimens used to treat women today, it is observational (which usually means the effects are overestimated) and it is from studies with inherent bias," Davies said.
"Women have the right to be fully informed to make their own choices, but this is not informing women about the overall benefit: risk ratio of menopausal care, but a highly precarious, unbalanced media grab."
Curry has since suggested HRT may be the only option for some women.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Sep 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Sep 19